Faisal Ghaffar 
Limerston Capital firm is concentrated on tactically expanding its functionality across the United States and Europe, with a special focus on Germany.
MET, which was established 25 years ago, offers advanced validation testing, as well as healthcare and combined effect devices, promised timeline testing. The corporation is recognized as a global leader in Contract Research Group for Needle Injectors and pre-filled needle testing, and it collaborates with the medical product and drug industry in over 20 countries across the middle east, Asia, and the United States, Europe, and Australasia.
MET offers genetic measurement and monitoring, human performance studies, packaged food validation, test methods, chemical classification, extractables and leachables, bioactivity studies, and toxic effects risk assessment. With the addition of MET, the team will be able to provide entire verification, discharge, and medical equipment testing to customers.
As part of the deal, funds will be allocated to support the established team and enlarge capabilities in response to customer demand. Mark Turner, the founder of MET, will step into the role of filmmaker, medical devices, and Mark Hammond, who’d been ordained Wickham Micro’s CEO earlier this year, will supervise the group. This additional acquisition provides a foundation for the future in the medical product and pharmacological testing markets, as well as proof of Limerston Capital’s dedication to Wickham Micro’s proposals.
The chance to work with the group at MET constitutes a substantial corner for the wider group, that is now stylish positioned to plump guests, helping to bring their medical outfit and meet the anticipated requests more snappily, stated Mark Hammond, CEO of Wickham Micro. MET is well-established.
“It’s an exciting moment for our business,” said Mark Turner, MET’s founder and Director of Medical Equipment. I’ve been appreciative to lead MET to this point, also with Mark’s help and the expert knowledge of the broader Wickham Micro squad, I’m looking forward to discovering how we can expand our assistance and attain, profiting our customers and helping us reach our maximum potential.”
Wickham Micro will now enhance its foothold in Europe, with such an emphasis on Germany, whereas exploring possibilities in the United States to enable further expansion.
“The procurement of Wickham Micro, followed quickly by the regards of MET shows clearly our aspirations in this space,” said Martim Avillez, founder and chairman of Limerston Capital. We have complete faith in Wickham Micro as well as MET.
